Janus International Group, Inc. current report, 05 August 2021

Janus International Group, Inc. — Form 8-K Summary

Business context and reporting period

Filed August 5, 2021, under Items 2.02, 7.01, and 9.01. Janus disclosed financial information from an excerpt of a lender presentation in connection with obtaining financing for its previously announced agreement to acquire DBCI. The filing does not present a conventional quarterly or annual reporting period.

Financial metrics

  • The filing references EBITDA and Adjusted EBITDA, including reconciliations to net income, but the provided filing text does not include the underlying amounts.
  • EBITDA and Adjusted EBITDA are non-GAAP measures and should not be considered substitutes for GAAP financial information.
  • The filing text does not provide clear values for revenue, net income, cash flow, margins, debt, liquidity, or other financial metrics.

Material changes versus the prior comparable period

The filing text does not provide a clear period-over-period comparison or identify quantified changes in operating or financial performance.

Guidance, outlook, risks, contingencies, and unusual items

  • The disclosed information relates to financing for the planned acquisition of DBCI.
  • Management uses EBITDA and Adjusted EBITDA to evaluate operations and cash flow and believes these measures provide additional comparisons with prior periods.
  • The filing does not provide acquisition terms, financing amounts, leverage levels, guidance, forecasts, contingencies, or specific risk factors in the supplied text.
  • The financial information was furnished under Regulation FD and was not deemed filed for purposes of Section 18 of the Exchange Act, except as expressly incorporated by reference.

Investor verification items

  1. Review Exhibit 99.1 for the actual lender-presentation figures and EBITDA-to-net-income reconciliations.
  2. Verify the financing structure, debt balance, interest terms, covenants, and liquidity impact associated with the DBCI acquisition.
  3. Assess the acquisition terms, expected closing conditions, and integration or execution risks.
  4. Confirm the definitions and adjustments used in Adjusted EBITDA and reconcile them to GAAP results.